Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Bain Capital
Biotech
PitchBook expects disciplined biopharma VC recovery in 2026
The biopharma VC market reflected a preference for de-risked assts over platforms and predicted a “continued, albeit disciplined” recovery in 2026.
Will Maddox
Feb 16, 2026 12:01am
Schizophrenia-minded Syremis takes off with $165M series A
Dec 18, 2025 12:59pm
Kailera raises hefty $600M to take Zepbound rival into ph. 3
Oct 14, 2025 9:20am
Areteia posts ph. 3 asthma win for oral rival to biologic drugs
Sep 16, 2025 9:20am
Apreo Health nets $130M to develop lung scaffold for emphysema
Aug 8, 2025 11:30am
BMS hands 5 autoimmune drugs to Bain-backed spinout
Jul 29, 2025 5:08am
